eCite Digital Repository
Type-2 Diabetes as a risk factor for severe COVID-19 infection
Citation
Norouzi, M and Norouzi, S and Ruggiero, A and Khan, MS and Myers, S and Kavanagh, K and Vemuri, R, Type-2 Diabetes as a risk factor for severe COVID-19 infection, Microorganisms, 9, (6) pp. 1-17. ISSN 2076-2607 (2021) [Refereed Article]
 | PDF (Published version) 2Mb |
Copyright Statement
Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License, (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
DOI: doi:10.3390/microorganisms9061211
Abstract
The current outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19), has generated a notable challenge for diabetic patients. Overall, people with diabetes have a higher risk of developing different infectious diseases and demonstrate increased mortality. Type 2 diabetes mellitus (T2DM) is a significant risk factor for COVID-19 progression and its severity, poor prognosis, and increased mortality. How diabetes contributes to COVID-19 severity is unclear; however, it may be correlated with the effects of hyperglycemia on systemic inflammatory responses and immune system dysfunction. Using the envelope spike glycoprotein SARS-CoV-2, COVID-19 binds to angiotensin-converting enzyme 2 (ACE2) receptors, a key protein expressed in metabolic organs and tissues such as pancreatic islets. Therefore, it has been suggested that diabetic patients are more susceptible to severe SARS-CoV-2 infections, as glucose metabolism impairments complicate the pathophysiology of COVID-19 disease in these patients. In this review, we provide insight into the COVID-19 disease complications relevant to diabetes and try to focus on the present data and growing concepts surrounding SARS-CoV-2 infections in T2DM patients.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | diabetes, SARS-CoV-2, immune response, adipose tissue, glucose metabolism, vaccines |
| Research Division: | Biological Sciences |
| Research Group: | Microbiology |
| Research Field: | Infectious agents |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Diagnosis of human diseases and conditions |
| UTAS Author: | Myers, S (Dr Stephen Myers) |
| UTAS Author: | Kavanagh, K (Associate Professor Kylie Kavanagh) |
| ID Code: | 145251 |
| Year Published: | 2021 |
| Web of Science® Times Cited: | 8 |
| Deposited By: | Health Sciences |
| Deposited On: | 2021-07-13 |
| Last Modified: | 2021-09-22 |
| Downloads: | 10 View Download Statistics |
Repository Staff Only: item control page